🇺🇸 FDA
Patent

US 8334260

sFRP and peptide motifs that interact with sFRP and methods of their use

granted A61KA61K38/00A61P

Quick answer

US patent 8334260 (sFRP and peptide motifs that interact with sFRP and methods of their use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/00, A61P, A61P1/02, A61P19/00